ImmuCell Corporation Common Stock (ICCC)

About ICCC

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield Fi…

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Employees

73

Website

immucell.com

Fundamentals

1-day range

$9.75$10.72

Market cap

$99.88M

P/E (trailing)

143.57

P/E (forward)

-91.36

EPS (trailing)

$0.07

Dividend yield

—

Beta

—

Avg. volume

30.5K

ImmuCell Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• ICCC

  ImmuCell Corporation Common Stock

  $9.94

  ▼ 0.80%
  Market cap $99.88MP/E 143.57
  $4.52$12.1
• IMDX

  Insight Molecular Diagnostics Inc. Common Stock

  $4.16

  ▼ 3.03%
  Market cap $162.42MP/E —
  $2.33$8.51
• CDIO

  Cardio Diagnostics Holdings Inc. Common stock

  $1.84

  ▼ 1.60%
  Market cap $4.85MP/E —
  $0.97$7.91
• BMRA

  Biomerica Inc. Common Stock

  $2.14

  ▲ 1.67%
  Market cap $4.73MP/E —
  $1.45$3.31
• VRAX

  Virax Biolabs Group Limited Ordinary Shares

  $2.82

  ▼ 4.08%
  Market cap $2.34MP/E —
  $2.5$21.75
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $284.15MP/E —
  $1.91$7.84
• ACHV

  Achieve Life Sciences Inc. Common Shares

  $8.09

  ▼ 1.16%
  Market cap $648.81MP/E —
  $2.62$8.61

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• ImmuCell Corporation 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/14/2026
• ImmuCell Corporation (ICCC) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/14/2026
• ImmuCell Reports Q2 2026 Results: Full Earnings Call Transcript
  Benzinga · 8/14/2026
• ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY
  Benzinga · 8/13/2026

• Boekhorst Paul Francis Olivier te · June 18, 2026 · Buy

  8.0K @ $9.5
• Gloria F. Basse · April 15, 2026 · Grant

  11.9K
• Turner Kathy V · April 15, 2026 · Grant

  17.9K
• Wainman Paul R · April 15, 2026 · Grant

  11.9K
• David Scott Tomsche · April 15, 2026 · Grant

  11.9K
• Michael F. Brigham · March 20, 2026 · Option Exercise

  25.0K @ $5.84
• Michael F. Brigham · March 20, 2026 · Tax Withholding

  24.1K @ $6.07

Institutional Ownership

March 31, 2026

Total shares held

1.33M

Total value held

$8.40M

Institutional holders

26